GDUFA III Reauthorization

Generic drug user fees make it possible for FDA and industry to continue to ensure that the American public has access to safe, effective and high-quality generic drugs. The implementation of the Generic Drug User Fee Amendments (GDUFA) encompasses a wide range of...

ADSTILADRIN

STN: BLA 125700Proper Name: nadofaragene firadenovec-vncgTradename: ADSTILADRINManufacturer: Ferring Pharmaceuticals A/SIndication: ADSTILADRIN is indicated for the treatment of adult patients with high-risk Bacillus Calmette-Guérin (BCG)-unresponsive non-Muscle...